Assessing the effects of supplementation with Nutrof® Total on the ability of the eye to filter blue light

Assessing the effects of supplementation with Nutrof® Total on macular pigment optical density

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN79841039

Enrollment

Registered

2013-11-21

Start date

2013-09-02

Completion date

Unknown

Last updated

2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular pigment, eye health, age related macular degeneration. Eye Diseases Senile macular degeneration (atrophic)(exudative)

Interventions

Subjects will be required to take one food supplement capsule (Nutrof® Total) daily, for 6 months. There is no placebo. Deviation from baseline measurement will be assessed.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Healthy volunteers recruited from local optometrists 2. Male or female 3. Aged 50 or older

Exclusion criteria

Exclusion criteria: 1. Type 1 and 2 diabetics 2. Pregnancy or intention to become pregnant 3. History of estrogen sensitive cancer 4. Warfarin users 5. Neovascular age-related macular degeneration (AMD) sufferers

Design outcomes

Primary

Measure	Time frame
Macular pigment optical density (MPOD) will be measured in the patients eye using a Tinsley® MPOD. These readings will be taken at baseline, 21 days, 3 months and 6 months.	—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026